News

AI-based screening for ROP may be more cost-effective than traditional screening modalities, but depends significantly on the added cost of AI.

“Incorporating patient perspectives will not only help better tailor therapies in this heterogeneous population but also identify treatment targets that are relevant to the individual patients," investigators explained.

The hope is society learns some of the lessons from the Cold War to better help patients with mental health concerns.

Dr. Lee highlights the process of identifying CTEPH and the patient population, as well as the available treatments for the condition.

The decision represents the first ever upadacitinib for a gastroenterological disease.

Rhythm Pharmaceuticals shares data from long-term extension study of setmelanotide in Bardet-Biedl Syndrome.

Investigators believe these results may aid shared decision-making between clinicians and patients.

Social media has had an influence on the mental health toll the war in the Ukraine is having.

Approximately 60% of patients with ulcerative colitis treated with guselkumab achieved clinical remission.

Apixaban prescription beyond 90 days showed no difference in hospitalization risk for major bleeding.

New data show the highest quintile of census-reported parental income is far more represented among future physicians than lower income levels, regardless of race.

ACR partners with the Vasculitis Foundation to establish a new guideline that addresses diagnostic issues relating to Kawasaki disease, a rare vasculitis that inflames the blood vessels.

Internalized skin bias also appeared to mediate the associations of depression and anxiety related to health-related quality of life.

The phase 3 trial was stopped following a formal interim assessment that met pre specified criteria for positive efficacy in patients with chronic kidney disease.

With several targeted therapies demonstrating positive trial results in lupus nephritis, the treatment paradigm appears to be shifting.

“Access to mental health services is a critical component of comprehensive care for patients suffering from rheumatologic disease,” investigators stated.

ChristianaCare’s Gene Editing Institute experts join the podcast to discuss the latest developments in gene editing.

An analysis of the EUROSTAD study found that the median duration of treatment with the biologic was 14 months.

The inhaler is approved for 2 strengths, 160/4.5 mcg/actuation and 80/4.5 mcg/actuation.

Novartis announces promising results from research evaluating the safety and efficacy of Zolgensma.

Children with unconfirmed PALs have prolonged hospital stays, higher rates of adverse events, and more infections due to Clostridium difficile and vancomycin-resistant Enterococcus.

The recurrent CDI cohort were nearly 10 times likelier to suffer from a CDI-associated death than the primary CDI cohort.

Data show LNCSBs as a substitute for sugar-sweetened beverages were associated with reduced body weight, BMI, percentage of body fat, and intrahepatocellular lipid.

A new post-hoc analyses for the sodium oxybate FT218 found that the therapy improved daytime sleepiness, sleep quality, and refreshing nature of sleep in patients with narcolepsy.

USPSTF experts noted a need for research into the benefits and harms of screening adults and adolescents without signs or symptoms.

Methotrexate is the first-line treatment for rheumatoid arthritis. As with all drugs, there is a risk of experiencing adverse effects. Do you know what type of adverse effects are most likely with methotrexate and who is likely to experience them? Take this quiz to find out.

Data show the absolute risk reductions of treatment with statins in terms of all-cause mortality, myocardial infarction, and stroke are modest compared with the relative risk reductions.

Karen Onel, MD, one of the lead investigators of the ACR's recent JIA treatment guidelines updates, explains important changes, treating patients with glucocorticoids, and the continued unmet needs in pediatric rheumatology.

More studies need to be done examining the associations of increased weight and outcomes among patients with cystic fibrosis.

Digital cognitive behavioral therapy for insomnia was the better option to patient education on all ratings for patients with self-reported morning or intermediate chronotypes.